Sirtuins in dermatology: Applications for future research and therapeutics

Archives of Dermatological Research

Volumn 305, Issue 4, 2013, Pages 269-282

  Serravallo, Melissa ^a   Jagdeo, Jared ^a,b,c   Glick, Sharon A ^a   Siegel, Daniel M ^a   Brody, Neil I ^a  

^a SUNY Downstate Medical Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Aging; Dermatology; Genodermatoses; Inflammation; Sirtuins; Skin cancer

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SIRTUIN; SIRTUIN 1; SIRTUIN 2; SIRTUIN 3; SIRTUIN 4; SIRTUIN 5; SIRTUIN 6; SIRTUIN 7; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATAXIA TELANGIECTASIA; ATOPIC DERMATITIS; BULLOUS SKIN DISEASE; CANDIDIASIS; COLLAGEN VASCULAR DISORDER; COWDEN SYNDROME; DEACETYLATION; DERMATOLOGY; DOWN REGULATION; DYSKERATOSIS CONGENITA; ENZYME ACTIVITY; HUMAN; HYPERTROPHIC SCAR; KELOID; MELANOMA SKIN CANCER; NON MELANOMA SKIN CANCER; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PSORIASIS; RUBINSTEIN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; UPREGULATION; VASCULAR DISEASE; WERNER SYNDROME; XERODERMA PIGMENTOSUM;

BIOMEDICAL RESEARCH; CELL AGING; DERMATOLOGY; HUMANS; SIRTUINS; SKIN AGING; SKIN DISEASES; THERAPEUTICS;

EID: 84885019598     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-013-1320-2     Document Type: Article

References (97)

1. Abel T, Zukin R (2008) Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. Curr Opin Pharmacol 8:57-64
2. Alcain F, Villalba J (2009) Sirtuin activators. Expert Opin Ther Pat 19:403-414
3. Alcain F, Villalba J (2009) Sirtuin inhibitors. Expert Opin Ther Pat 19:283-294
4. Allison S, Jiang M, Milner J (2009) Oncogenic viral protein HPV E7 up-regulates the SIRT1 longevity protein in human cervical cancer cells. Aging 1:316-327
5. Back J, Rezvani H, Zhu Y, Guyonnet-Duperat V, Athar M et al (2011) Cancer cell survival following DNA damage-mediated premature senescence is regulated by mammalian target of rapamycin (mTOR)-dependent inhibition of sirtuin 1. J Biol Chem 286:19100-19108
6. Baker D, Wijshake T, Tchkonia T, LeBrasseur N, Childs B et al (2011) Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479:232-237
7. Baohua Y, Li L (2012) Effects of SIRT6 silencing on collagen metabolism in human dermal fibroblasts. Cell Biol Int 36:105-108
8. Benavente C, Schnell S, Jacobson E (2012) Effects of niacin restriction on sirtuin and PARP responses to photodamage in human skin. PLoS ONE 7:e42276. doi: 10.1371/journal.pone.0042276
9. Bennett K, Mester J, Eng C (2010) Germline epigenetic regulation of KILLIN in Cowden and Cowden-like syndrome. JAMA 304:2724-2731
10. Blander G, Bhimavarapu A, Mammone T, Maes D, Elliston K et al (2009) SIRT1 promotes differentiation of normal human keratinocytes. J Invest Dermatol 129:41-49
11. Bordone L, Motta M, Picard F, Robinson A, Jhala U et al (2006) Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells. PLoS Biol 4:e31
12. Bouras T, Fu M, Sauve A, Wang F, Quong A et al (2005) SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1. J Biol Chem 280:10264-10276
13. Calado R, Young N (2009) Telomere diseases. N Engl J Med 361:2353-2365
14. Camins A, Sureda F, Junyent F, Verdaguer E, Folch J et al (2010) Sirtuin activators: designing molecules to extend life span. Biochim Biophys Acta 1799:740-749
15. Campisi J, Yaswen P (2009) Aging and cancer cell biology. Aging Cell 8:221-225
16. 2-induced cell death via modulation of p53 and JNK in cultured skin keratinocytes. J Cell Mol Med 13:3632-3643
17. Chen M, Li J, Xiao W, Sun L, Tang H et al (2006) Protective effect of resveratrol against oxidative damage of UVA irradiated HaCaT cells. J Central South Univ 31:635-639
18. Civitarese A, Carling S, Heilbronn L, Hulver M, Ukropcova B et al (2007) Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med 4:e76
19. ClinicalTrials.gov. (1993-) US National Institute of Health. http://clinicaltrials.gov/ct2/search. Accessed September 1, 2012
20. Cohen H, Miller C, Bitterman K, Wall N, Hekking B et al (2004) Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305:390-392
21. Colman R, Anderson R, Johnson S, Kastman E, Kosmatka K et al (2009) Caloric restriction delays disease onset and mortality in rhesus monkey. Science 325:201-204
22. Dai J, Wang Z, Sun D, Lin R, Wang S (2007) SIRT1 interacts with p73 and suppresses p73-dependent transcriptional activity. J Cell Physiol 210:161-166
23. DeFelice B, Wilson R, Nacca M (2009) Telomere shortening may be associated with human keloids. BMC Med Genet 10:110
24. Denu J (2003) Linking chromatin function with metabolic networks: Sir2 family of NAD(+)-dependent deacetylases. Trends Biochem Sci 28:41-48
25. Donmez G, Guarente L (2010) Aging and disease: connection to sirtuins. Aging Cell 9:285-290
26. Dryden S, Nahhas F, Nowak J, Goustin A, Tainsky M (2003) Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle. Mol Cell Biol 23:3173-3185
27. Emanuele E, Bertona M, Altabas K, Altabas V, Alessandrini G (2012) Anti-inflammatory effects of a topical preparation containing nicotinamide, retinol, and 7-dehydrocholesterol in patients with acne: a gene expression study. Clin Cosmet Investig Dermatol 5:33-37
28. Espada J, Ballestar E, Santoro R, Fraga M, Villar-Garea A et al (2007) Epigenetic disruption of ribosomal RNA genes and nucleolar architecture in DNA methyltransferase 1 (Dnmt1) deficient cells. Nucleic Acids Res 35:2191-2198
29. Fan W, Luo J (2010) SIRT1 regulates UV-induced DNA repair through deacetylating XPA. Mol Cell 39:247-258
30. Ferreux E, Lont A, Horenblas S, Gallee M, Raaphorst F et al (2003) Evidence for at least three alternative mechanisms targeting the p16INK4A/cyclin D/Rb pathway in penile carcinoma, one of which is mediated by high-risk human papillomavirus. J Pathol 201:109-118
31. Ford E, Voit R, Liszt G, Magin C, Grummt I, Guarente L (2006) Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription. Genes Dev 20:1075-1080
32. Gao J, Wang W, Mao Y, Gräff J, Guan J et al (2010) A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature 466:1105-1109
33. Gao Z, Ye J (2008) Inhibition of transcriptional activity of c-JUN by SIRT1. Biochem Biophys Res Commun 376:793-796
34. Goihman-Yahr M (1996) Skin aging and photoaging: an outlook. Clin Dermatol 14:153-160
35. Guarente L (2008) Mitochondria - A nexus for aging, calorie restriction, and sirtuins? Cell 132:171-176
36. Guarente L, Picard F (2005) Calorie restriction - the SIR2 connection. Cell 120:473-482
37. Haigis M, Mostoslavsky R, Haigis K, Fahie K, Christodoulou D et al (2006) SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell 126:941-954
38. Haigis M, Sinclair D (2010) Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol 5:253-295
39. Hida Y, Kubo Y, Murao K, Arase S (2007) Strong expression of a longevity-related protein, SIRT1, in Bowen's disease. Arch Dermatol Res 299:103-106
40. Hu N, Long H, Zhao M, Yin H, Lu Q (2009) Aberrant expression pattern of histone acetylation modifiers and mitigation of lupus by SIRT1-siRNA in MRL/lpr mice. Scand J Rheumatol 38:464-471
41. Huang D, Ostrosky-Zeichner L, Wu J, Pang K, Tyring S (2004) Therapy of common superficial fungal infections. Dermatol Ther 17:517-522
42. Inoue T, Hiratsuka M, Osaki M, Yamada H, Hishimoto I et al (2007) SIRT2, a tubulin deacetylase, acts to block the entry to chromosome condensation in response to mitotic stress. Oncogene 26:945-957
43. Jin Y, Kim Y, Kim D, Baek K, Kang B et al (2008) Sirt2 interacts with 14-3-3 beta/gamma and down-regulates the activity of p53. Biochem Biophys Res Commun 368:690-695
44. Kalergis A, Iruretagoyena M, Barrientos M, Gonzalez P, Herrada A et al (2008) Modulation of nuclear factor-kappaB activity can influence the susceptibility to systemic lupus erythematosus. Immunology 128(1 Suppl):e306-e314
45. Kawahara T, Michishita E, Adler A, Damian M, Berber E et al (2009) SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell 136:62-74
46. Keppler B, Archer T (2008) Chromatin-modifying enzymes as therapeutic targets - Part 1. Expert Opin Ther Targets 12:1301-1312
47. Knoch J, Kamenisch Y, Kubisch C, Berneburg M (2012) Rare hereditary diseases with defects in DNA-repair. Eur J Dermatol 22:443-455
48. Kume S, Haneda M, Kanasaki K, Sugimoto T, Araki S et al (2007) SIRT1 inhibits transforming growth factor beta-induced apoptosis in glomerular mesangial cells via Smad7 deacetylation. J Biol Chem 282:151-158
49. Lain S, Hollick J, Campbell J, Staples O, Higgins M et al (2008) Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator. Cancer Cell 13:454-463
50. Lasserre C, D'Arcangelis A, Mildner M, Bhatt P, Tschachler E (2007) The effect of ultraviolet irradiation on sirtuin expression in human skin. J Invest Dermatol 127:S57. doi: 10.1038/sj.jid.5701090
51. Lee J, Park K, Min H, Lee S, Kim J et al (2010) Negative regulation of stress-induced matrix metalloproteinase-9 by Sirt1 in skin tissue. Exp Dermatol 19:1060-1066
52. Lennerz V, Fatho M, Gentilini C, Frye R, Lifke A et al (2005) The response of autologous T cells to a human melanoma is dominated by mutated neoantigens. Proc Natl Acad Sci USA 102:16013-16018
53. Li L, Wu L, Tashiro S, Onodera S, Uchiumi F, Ikejima T (2007) Activation of the SIRT1 pathway and modulation of the cell cycle were involved in silymarin's protection against UV-induced A375-S2 cell apoptosis. J Asian Nat Prod Res 9:242-252
54. Li X, Zhang S, Blander G, Tse J, Krieger M, Guarente L (2007) SIRT1 deacetylates and positively regulates the nuclear receptor LXR. Mol Cell 28:91-106
55. Liszt G, Ford E, Kurtev M, Guarente L (2005) Mouse Sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferase. J Biol Chem 280:21313-21320
56. Lombard D, Chua K, Mostoslavsky R, Franco S, Gostissa M (2005) DNA repair, genome stability, and aging. Cell 120:497-512
57. Markovic S, Erickson L, Rao R, Weenig R, Pockaj B et al (2007) Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc 82:364-380
58. Menter A, Gottlieb A, Feldman S, Voorhees AV, Leonardi C et al (2008) Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol 58:826-850
59. Michan S, Sinclair D (2007) Sirtuins in mammals: insights into their biological function. Biochem J 404:1-13
60. Michishita E, McCord R, Berber E, Kioi M, Padilla-Nash H et al (2008) SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature 452:492-496
61. Michishita E, Park J, Burneskis J, Barrett J, Horikawa I (2005) Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell 16:4623-4635
62. Ming M, Shea C, Guo X, Li X, Soltani K et al (2010) Regulation of global genome nucleotide excision repair by SIRT1 through xeroderma pigmentosum C. Proc Natl Acad Sci USA 107:22623-22628
63. Moreau M, Neveu M, Stephan S, Noblesse E, Nizard C et al (2007) Enhancing cell longevity for cosmetic application: a complementary approach. J Drugs Dermatol 6:s14-s19
64. Mostoslavsky R, Chua K, Lombard D, Pang W, Fischer M et al (2006) Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 124:315-329
65. Motta M, Divecha N, Lemieux M, Kamel C, Chen D, Gu W et al (2004) Mammalian SIRT1 represses forkhead transcription factors. Cell 116:551-563
66. Nagel A, Hert M, Eming R (2009) B-cell-directed therapy for inflammatory skin diseases. J Invest Dermatol 129:289-301
67. Nakamaru Y, Vuppusetty C, Wada H, Milne J, Ito M et al (2009) A protein deacetylase SIRT1 is a negative regulator of metalloproteinase-9. FASEB J 23:2810-2819
68. Navarrete-Solís J, Castanedo-Cázares J, Torres-Álvarez B, Oros-Ovalle C, Fuentes-Ahumada C et al (2011) A double-blind, randomized clinical trial of niacinamide 4% versus hydroquinone 4% in the treatment of melasma. Dermatol Res Pract 2011:379173-379177
69. Peng L, Yuan Z, Ling H, Fukasawa K, Robertson K et al (2011) SIRT1 deacetylates the DNA methyltransferase 1 (DNMT1) protein and alters its activities. Mol Cell Biol 31:4720-4734
70. Picard F, Kurtev M, Chung N, Topark-Ngarm A, Senawong T et al (2004) Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429:771-776
71. Pradhan S, Girish C (2006) Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. Indian J Med Res 124:491-504
72. Rajamohan S, Pillai V, Gupta M, Sundaresan N, Birukov K et al (2009) SIRT1 promotes cell survival under stress by deacetylation-dependent deactivation of poly(ADP-ribose) polymerase 1. Mol Cell Biol 29:4116-4129
73. Rogers H, Weinstock M, Harris A, Hinckley M, Feldman S et al (2010) Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 146:283-287
74. Rothfield N, Sontheimer R, Bernstein M (2006) Lupus erythematosus: systemic and cutaneous manifestations. Clin Dermatol 24:348-362
75. Ruhnke M (2006) Epidemiology of Candida albicans infections and role of non-Candida albicans yeasts. Curr Drug Targets 7:495-504
76. Salimen A, Kaarniranta K (2009) NF-kappaB signaling in the aging process. J Clin Immunol 29:397-405
77. Scher M, Vaquero A, Reinberg D (2007) SirT3 is a nuclear NAD+-dependent histone deacetylase that translocates to the mitochondria upon cellular stress. Genes Dev 21:920-928
78. Schlicker C, Gertz M, Papatheodorou P, Kachholz B, Becker C, Steegborn C (2008) Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5. J Mol Biol 382:790-801
79. Schwer B, Bunkenborg J, Verdin R, Andersen J, Verdin E (2006) Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2. Proc Natl Acad Sci USA 103:10224-10229
80. Sequiera J, Boily G, Bazinet S, Saliba S, He X et al (2008) Sirt1-null mice develop an autoimmune-like condition. Exp Cell Res 314:3069-3074
81. Shih B, Bayat A (2010) Genetics of keloid scarring. Arch Dermatol Res 302:319-339
82. Sundaresan N, Samant S, Pillai V, Rajamohan S, Gupta M (2008) SIRT3 is a stress-responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku70. Mol Cell Biol 28:6384-6401
83. Surjana D, Halliday G, Martin A, Moloney F, Damian D (2012) Oral nicotinamide reduces actinic keratoses in phase II double-blinded randomized controlled trials. J Invest Dermatol 132:1497-1500
84. Turner B (2000) Histone acetylation and an epigenetic code. BioEssays 22:836-845
85. VanGool F, Galli M, Gueydan C, Kruys V, Bedalov A et al (2009) Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner. Nat Med 15:206-210
86. Vaquero A, Scher M, Lee D, Erdjument-Bromage H, Tempst P, Reinberg D (2004) Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin. Mol Cell 16:93-105
87. Vaziri H, Dessain S, Ng E, Imai S, Frye R et al (2001) hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107:149-159
88. Wang C, Chen L, Hou X, Li Z, Kabra N et al (2006) Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage. Nat Cell Biol 8:1025-1031
89. Wang C, Wang M, Tashiro S, Onodera S, Ikejima T (2005) Roles of SIRT1 and phosphoinositide 3-OH kinase/protein kinase C pathways in evodiamine-induced human melanoma A375-S2 cell death. J Pharmacol Sci 97:494-500
90. Wang F, Nguyen M, Qin FX, Tong Q (2007) SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction. Aging Cell 6:505-514
91. Wang J, Chen J (2010) SIRT1 regulates autoacetylation and histone acetyltransferase activity of TIP60. J Biol Chem 285:11458-11464
92. Wong S, Weber J (2007) Deacetylation of the retinoblastoma tumour suppressor protein by SIRT1. Biochem J 407:451-460
93. Wurtele H, Tsao S, Lépine G, Mullick A, Tremblay J et al (2010) Modulation of histone H3 lysine 56 acetylation as an antifungal therapeutic strategy. Nat Med 16:774-780
94. Yeung F, Hoberg J, Ramsey C, Keller M, Jones D et al (2004) Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23:2369-2380
95. Yuan H, Marmorstein R (2012) Structural basis for sirtuin activity and inhibition. J Biol Chem 287:42428-42435
96. Yuan Z, Zhang X, Sengupta N, Lane W, Seto E (2007) SIRT1 regulates the function of the Nijmegen breakage syndrome protein. Mol Cell 27:149-162
97. Zhu X, Liu Q, Wang M, Liang M, Yang X et al (2011) Activation of Sirt1 by resveratrol inhibits TNF-a induced inflammation in fibroblasts. PLoS ONE 6:e27081